Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1432-0843
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia ; day:8 ; month:1 ; year:2021 ; pages:1-11
Cancer chemotherapy and pharmacology ; (8.1.2021), 1-11

Creator
Kang, Dongwoo
Ludwig, Elizabeth
Jaworowicz, David
Huang, Hannah
Fiedler-Kelly, Jill
Cortes, Jorge
Ganguly, Siddhartha
Khaled, Samer
Krämer, Alwin
Levis, Mark
Martinelli, Giovanni
Perl, Alexander
Russell, Nigel
Abutarif, Malaz
Choi, Youngsook
Yin, Ophelia
Contributor
SpringerLink (Online service)

DOI
10.1007/s00280-020-04204-y
URN
urn:nbn:de:101:1-2021020820414818391266
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:38 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Kang, Dongwoo
  • Ludwig, Elizabeth
  • Jaworowicz, David
  • Huang, Hannah
  • Fiedler-Kelly, Jill
  • Cortes, Jorge
  • Ganguly, Siddhartha
  • Khaled, Samer
  • Krämer, Alwin
  • Levis, Mark
  • Martinelli, Giovanni
  • Perl, Alexander
  • Russell, Nigel
  • Abutarif, Malaz
  • Choi, Youngsook
  • Yin, Ophelia
  • SpringerLink (Online service)

Other Objects (12)

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia

Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia

Gilteritinib versus chemotherapy in Japanese patients with FLT3-mutated relapsed/refractory acute myeloid leukemia

Management of relapsed-refractory diffuse large B cell lymphoma

Management of relapsed-refractory diffuse large B cell lymphoma

CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia

CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia

Advances in the treatment of relapsed/refractory chronic lymphocytic leukemia

Update on the management of relapsed/refractory chronic lymphocytic leukemia

Update on the management of relapsed/refractory chronic lymphocytic leukemia

Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports

Practical Considerations for Treatment of Relapsed/Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia

Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/Refractory Multiple Myeloma

Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/Refractory Multiple Myeloma

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

Emerging therapies for relapsed/refractory multiple myeloma: CAR-T and beyond

Fluorodeoxyglucose-Positron Emission Tomography in Relapsed/Refractory Hodgkin Lymphoma: A Practical Approach

Fluorodeoxyglucose-Positron Emission Tomography in Relapsed/Refractory Hodgkin Lymphoma: A Practical Approach

Related objects